Peptide Glazing Fluid is Rhode's founding product and one of the most-searched peptide serums in the US. Its name puts the peptide first. The full ingredient list is published on the brand's own product page, so the question the name raises — which peptide, and how prominent — can be answered from the declaration itself. This analysis reads the list position by position and sets the page's claims beside the published research. Nobody at this journal has put the fluid on their skin, so what follows is the label and the literature, not an experience of the product.
The declaration
Copied from rhodeskin.com (US), read on 3 October 2026. Each slash-joined name counts as one ingredient.
| # | Ingredient | # | Ingredient |
|---|---|---|---|
| 1 | Water | 12 | Caprylyl Glycol |
| 2 | Glycerin | 13 | Glyceryl Oleate |
| 3 | Butylene Glycol | 14 | Dilauryl Thiodipropionate |
| 4 | Sclerocarya Birrea (Marula) Seed Oil | 15 | Acrylates/C10-30 Alkyl Acrylate Crosspolymer |
| 5 | Niacinamide | 16 | Carbomer |
| 6 | Tetradecane | 17 | Sucrose Palmitate |
| 7 | Capryloyl Glycerin/Sebacic Acid Copolymer | 18 | Sodium Phosphate |
| 8 | Diheptyl Succinate | 19 | Disodium Phosphate |
| 9 | Acetyl Hexapeptide-8 | 20 | Phenoxyethanol |
| 10 | Sodium Hyaluronate | 21 | Sodium Hydroxide |
| 11 | Hydroxyacetophenone | 22 | Benzyl Alcohol |
Finding 1: one peptide, ninth of 22, and the page does not name it
The list declares exactly one peptide: acetyl hexapeptide-8, at position 9. The product page's ingredient glossary describes it only as "PEPTIDE — a short chain of amino acids that smooths and revitalizes skin, improving radiance". The name a shopper would need to look the ingredient up appears only in the ingredient list.
Above it sit water, two humectants (glycerin, butylene glycol), marula oil, niacinamide, and three ingredients that give the texture and slip of a light fluid: tetradecane, a capryloyl glycerin/sebacic acid copolymer and diheptyl succinate. Below it come sodium hyaluronate, two preservative boosters, two thickening polymers, a buffer pair and the preservatives.
Finding 2: what acetyl hexapeptide-8 was designed for
Acetyl hexapeptide-8 is the peptide sold as Argireline. It is six amino acids with an acetylated start and an amidated end, 887.0 g/mol in PubChem (CID 71587772). It was designed to mimic the start of SNAP-25, one of the proteins that releases the chemical signal telling a muscle to contract, and so to soften lines made by repeated facial expression. Our Argireline page sets out the record in full; the short version is:
| What was studied | What was found |
|---|---|
| Original 2002 study, 10% emulsion, 30 days | Wrinkle depth reduced by up to 30%; abstract gives no volunteer count and no control |
| Randomized placebo-controlled trial, 60 people, periorbital wrinkles, 4 weeks (Wang 2013) | Anti-wrinkle efficacy reported in 48.9% on the peptide and 0% on placebo |
| FDA in-vitro penetration study, 10% emulsion on human skin | 0.22% of the dose in the outer layer and 0.01% in the epidermis after 24 hours |
| US Cosmetic Ingredient Review safety assessment | Safe as used up to 0.005%; data insufficient above that |
On 3 October 2026, PubMed held 47 records under acetyl hexapeptide-8, its older name acetyl hexapeptide-3, or Argireline. Two are tagged as randomized controlled trials: the 60-person wrinkle trial above, and a 2013 pilot in patients with blepharospasm (an eyelid-spasm condition) receiving botulinum toxin.
The outcome every one of those studies measured is expression lines. "Radiance", "glow" and "plumping" — the three effects Peptide Glazing Fluid's page leads with — are not what the ingredient was designed or tested for.
Finding 3: niacinamide sits four places higher
Niacinamide, a form of vitamin B3, is fifth on the list. The brand's glossary credits it with brightening and texture. Its published record on skin is far larger than the peptide's: PubMed returned 49 records tagged as randomized controlled trials for niacinamide and skin on 3 October 2026, against 2 for acetyl hexapeptide-8 under the same filter. By position and by evidence, this is a niacinamide fluid that also contains a peptide.
The finish the brand describes — "instantly dewy and luminous" — is also what glycerin (second), marula oil (fourth) and the film-forming and emollient ingredients at positions 6 to 8 do on contact with skin, without any biological mechanism at all.
Finding 4: position is not amount
Under US rules, ingredients must be listed in descending order of amount only down to the 1% line; at or below 1% they may follow in any order (21 CFR 701.3(f)(2)). Phenoxyethanol at position 20 is normally used at up to 1% (the EU's limit for it as a preservative), so everything from 20 down is at or under that level. The peptide at 9 is above it, but that does not bound the peptide from below: the list gives no amount, and the US safety panel's assessment of acetyl hexapeptide-8 covered concentrations up to 0.005%. The 2002 study and FDA's penetration study both used 10% emulsions; the 60-person trial's abstract does not state a concentration. Our guide to reading a peptide ingredient list explains why position alone cannot answer "how much".
The page's claims against its evidence
| Product-page claim | What the page supplies |
|---|---|
| "Hydrates and brightens skin" | Glycerin second, niacinamide fifth, sodium hyaluronate tenth |
| "Instantly illuminates for a glazed finish" | Oils and emollients at 4, 6, 7, 8 — a contact effect |
| "Visibly plumps skin over time" | No measurement cited |
| "92% agreed skin felt hydrated after one use" | Consumer perception study, "48+ people" |
| "87% agreed it absorbed quickly upon application" | Same study |
| "87% agreed it provided a glowy, radiant finish after 30 days" | Same study |
All three percentages come from what the page itself calls "a consumer perception study of 48+ people": participants said whether they agreed with a statement. None is an instrument measurement of hydration, wrinkle depth or skin thickness, and no comparison product is described. The same pattern appears on Rhode's lip product, read on our Rhode Peptide Lip Treatment analysis, whose one peptide is a different one (palmitoyl tripeptide-1). Rhode's moisturiser carries the same kind of figure from 46 people; see our Barrier Restore Cream analysis.
The page also directs application to "face, neck, and décolleté". Our census of peptide trials by body site, on the peptide serum for face page, found no trial naming a non-facial site. Four dedicated neck products and the neck studies are read on our page about neck creams with peptides.
What it costs
Listed on 3 October 2026: $32 for 1.7 fl oz (about 50 mL, $0.64 per mL) and $20 for 0.5 fl oz (about 15 mL, $1.33 per mL).
Questions the label leaves open
- How much acetyl hexapeptide-8 the fluid contains. Rhode does not publish it.
- Whether the peptide at this formula's concentration has any measurable effect on expression lines. No study of this product is published.
- How the consumer study was run, beyond its size and its three statements.
Related reading on this site
For the ingredient itself, see Argireline, and for the other peptides designed to act on expression lines, SNAP-8 and SYN-AKE. For the serum category, see our peptide serum guide and what peptides do for skin. Another serum read the same way: The Ordinary Multi-Peptide + HA Serum.
Sources
- Rhode, Peptide Glazing Fluid product page, ingredient list, glossary, consumer-study figures and prices, rhodeskin.com, read 3 October 2026.
- PubChem compound 71587772 (acetyl hexapeptide-8), molecular weight, read 3 October 2026.
- PubMed E-utilities searches, 3 October 2026: acetyl hexapeptide-8 / acetyl hexapeptide-3 / Argireline (47; 2 tagged randomized controlled trial, PMIDs 23417317 and 23146065); niacinamide and skin, "randomized controlled trial"[pt] (49).
- Wang Y et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. American Journal of Clinical Dermatology 2013 (PMID 23417317).
- Blanes-Mira C et al., International Journal of Cosmetic Science 2002; Kraeling et al., Cutaneous and Ocular Toxicology 2015; Cosmetic Ingredient Review final report on acetyl hexapeptide-8 — as summarised, with links, on our Argireline page.
- US Code of Federal Regulations, 21 CFR 701.3(f)(2) — the rule that lets ingredients at 1% or less, such as the peptide at ninth, appear in any order.